Three conformational snapshots of the hepatitis C virus NS3 helicase reveal a ratchet translocation mechanism.

PubWeight™: 1.94‹?› | Rank: Top 2%

🔗 View Article (PMC 2818896)

Published in Proc Natl Acad Sci U S A on December 31, 2009

Authors

Meigang Gu1, Charles M Rice

Author Affiliations

1: Laboratory of Virology and Infectious Disease, Center for the Study of Hepatitis C, The Rockefeller University, New York, NY 10065, USA. mgu@rockefeller.edu

Articles citing this

SF1 and SF2 helicases: family matters. Curr Opin Struct Biol (2010) 3.79

Structural insights into RNA recognition by RIG-I. Cell (2011) 3.25

Structural basis of RNA recognition and activation by innate immune receptor RIG-I. Nature (2011) 3.05

Understanding the hepatitis C virus life cycle paves the way for highly effective therapies. Nat Med (2013) 2.63

RNA helicases at work: binding and rearranging. Trends Biochem Sci (2011) 2.42

Conventional and unconventional mechanisms for capping viral mRNA. Nat Rev Microbiol (2011) 1.61

Hepatitis C virus non-structural protein 3 (HCV NS3): a multifunctional antiviral target. J Biol Chem (2010) 1.58

Visualizing ATP-dependent RNA translocation by the NS3 helicase from HCV. J Mol Biol (2010) 1.38

Single-base pair unwinding and asynchronous RNA release by the hepatitis C virus NS3 helicase. Science (2011) 1.31

Comparative structural analysis of human DEAD-box RNA helicases. PLoS One (2010) 1.21

Processive translocation mechanism of the human Bloom's syndrome helicase along single-stranded DNA. Nucleic Acids Res (2010) 1.08

Staufen2 functions in Staufen1-mediated mRNA decay by binding to itself and its paralog and promoting UPF1 helicase but not ATPase activity. Proc Natl Acad Sci U S A (2012) 1.06

The protease domain increases the translocation stepping efficiency of the hepatitis C virus NS3-4A helicase. J Biol Chem (2010) 1.06

Fitting CRISPR-associated Cas3 into the helicase family tree. Curr Opin Struct Biol (2014) 1.04

Sequence-dependent base pair stepping dynamics in XPD helicase unwinding. Elife (2013) 1.02

Identification and analysis of hepatitis C virus NS3 helicase inhibitors using nucleic acid binding assays. Nucleic Acids Res (2012) 1.00

Molecular insights into DNA interference by CRISPR-associated nuclease-helicase Cas3. Proc Natl Acad Sci U S A (2014) 1.00

Unmasking the active helicase conformation of nonstructural protein 3 from hepatitis C virus. J Virol (2011) 0.97

Tracing entire operation cycles of molecular motor hepatitis C virus helicase in structurally resolved dynamical simulations. Proc Natl Acad Sci U S A (2010) 0.96

One small step for Mot1; one giant leap for other Swi2/Snf2 enzymes? Biochim Biophys Acta (2011) 0.93

The macroscopic rate of nucleic acid translocation by hepatitis C virus helicase NS3h is dependent on both sugar and base moieties. J Mol Biol (2010) 0.93

The core protein of classical Swine Fever virus is dispensable for virus propagation in vitro. PLoS Pathog (2012) 0.91

Human RECQ1 helicase-driven DNA unwinding, annealing, and branch migration: insights from DNA complex structures. Proc Natl Acad Sci U S A (2015) 0.90

Functional cross-talk between distant domains of chikungunya virus non-structural protein 2 is decisive for its RNA-modulating activity. J Biol Chem (2014) 0.90

Superfamily 2 helicases. Front Biosci (Landmark Ed) (2012) 0.89

Regulation of Deinococcus radiodurans RecA protein function via modulation of active and inactive nucleoprotein filament states. J Biol Chem (2013) 0.88

Molecular dynamics simulation in virus research. Front Microbiol (2012) 0.87

Grip it and rip it: structural mechanisms of DNA helicase substrate binding and unwinding. Protein Sci (2014) 0.86

Structural mechanisms of DNA binding and unwinding in bacterial RecQ helicases. Proc Natl Acad Sci U S A (2015) 0.86

Discovering new medicines targeting helicases: challenges and recent progress. J Biomol Screen (2013) 0.85

The Ighmbp2 helicase structure reveals the molecular basis for disease-causing mutations in DMSA1. Nucleic Acids Res (2012) 0.84

Structures of hepatitis C virus nonstructural proteins required for replicase assembly and function. Curr Opin Virol (2013) 0.84

Crystal structure, mutational analysis and RNA-dependent ATPase activity of the yeast DEAD-box pre-mRNA splicing factor Prp28. Nucleic Acids Res (2014) 0.83

Ebselen inhibits hepatitis C virus NS3 helicase binding to nucleic acid and prevents viral replication. ACS Chem Biol (2014) 0.83

Stepwise nucleosome translocation by RSC remodeling complexes. Elife (2016) 0.83

Aurintricarboxylic acid modulates the affinity of hepatitis C virus NS3 helicase for both nucleic acid and ATP. Biochemistry (2013) 0.82

Mycobacterium smegmatis SftH exemplifies a distinctive clade of superfamily II DNA-dependent ATPases with 3' to 5' translocase and helicase activities. Nucleic Acids Res (2012) 0.82

Helicase-mediated changes in RNA structure at the single-molecule level. RNA Biol (2013) 0.82

Mechanism of chromatin remodelling revealed by the Snf2-nucleosome structure. Nature (2017) 0.82

In silico investigation of conformational motions in superfamily 2 helicase proteins. PLoS One (2011) 0.81

Toward a crystal-clear view of the viral RNA sensing and response by RIG-I-like receptors. RNA Biol (2014) 0.80

Translocation-coupled DNA cleavage by the Type ISP restriction-modification enzymes. Nat Chem Biol (2015) 0.80

Hepatitis C virus RNA replication depends on specific cis- and trans-acting activities of viral nonstructural proteins. PLoS Pathog (2015) 0.80

Benzothiazole and Pyrrolone Flavivirus Inhibitors Targeting the Viral Helicase. ACS Infect Dis (2015) 0.80

Mycobacterium smegmatis Lhr Is a DNA-dependent ATPase and a 3'-to-5' DNA translocase and helicase that prefers to unwind 3'-tailed RNA:DNA hybrids. J Biol Chem (2013) 0.79

Structure-based simulations of the translocation mechanism of the hepatitis C virus NS3 helicase along single-stranded nucleic acid. Biophys J (2012) 0.79

X-ray structure of the pestivirus NS3 helicase and its conformation in solution. J Virol (2015) 0.79

Kinetics of DNA unwinding by the RecD2 helicase from Deinococcus radiodurans. J Biol Chem (2010) 0.79

Melting of Duplex DNA in the Absence of ATP by the NS3 Helicase Domain through Specific Interaction with a Single-Strand/Double-Strand Junction. Biochemistry (2015) 0.78

Primuline derivatives that mimic RNA to stimulate hepatitis C virus NS3 helicase-catalyzed ATP hydrolysis. J Biol Chem (2013) 0.78

Binding by the hepatitis C virus NS3 helicase partially melts duplex DNA. Biochemistry (2012) 0.78

ATP dependent NS3 helicase interaction with RNA: insights from molecular simulations. Nucleic Acids Res (2015) 0.78

Cloning and expression of NS3 helicase fragment of hepatitis C virus and the study of its immunoreactivity in HCV infected patients. Iran J Basic Med Sci (2015) 0.77

Hepatitis C virus NS3 inhibitors: current and future perspectives. Biomed Res Int (2013) 0.77

Unwinding initiation by the viral RNA helicase NPH-II. J Mol Biol (2011) 0.77

ATSAS 2.8: a comprehensive data analysis suite for small-angle scattering from macromolecular solutions. J Appl Crystallogr (2017) 0.77

The Spring α-Helix Coordinates Multiple Modes of HCV (Hepatitis C Virus) NS3 Helicase Action. J Biol Chem (2016) 0.75

Comparison of structural architecture of HCV NS3 genotype 1 versus Pakistani genotype 3a. Biomed Res Int (2014) 0.75

Computational biology approach to uncover hepatitis C virus helicase operation. World J Gastroenterol (2014) 0.75

Functional link between DEAH/RHA helicase Prp43 activation and ATP base binding. Nucleic Acids Res (2017) 0.75

Docking studies of Pakistani HCV NS3 helicase: a possible antiviral drug target. PLoS One (2014) 0.75

Polyprotein-Driven Formation of Two Interdependent Sets of Complexes Supporting Hepatitis C Virus Genome Replication. J Virol (2015) 0.75

Nonstructural protein 5A (NS5A) and human replication protein A increase the processivity of hepatitis C virus NS5B polymerase activity in vitro. J Virol (2014) 0.75

Molecular mechanism of divalent-metal-induced activation of NS3 helicase and insights into Zika virus inhibitor design. Nucleic Acids Res (2016) 0.75

Profile of Charles M. Rice. Proc Natl Acad Sci U S A (2011) 0.75

Analysis of the Enzymatic Activity of an NS3 Helicase Genotype 3a Variant Sequence Obtained from a Relapse Patient. PLoS One (2015) 0.75

RHAU helicase stabilizes G4 in its nucleotide-free state and destabilizes G4 upon ATP hydrolysis. Nucleic Acids Res (2016) 0.75

An aromatic-rich loop couples DNA binding and ATP hydrolysis in the PriA DNA helicase. Nucleic Acids Res (2016) 0.75

Structure of DEAH/RHA ATPase Prp43p bound to RNA implicates a pair of hairpins and motif Va in translocation along RNA. RNA (2017) 0.75

A glimpse into chromatin remodeling. Nat Struct Mol Biol (2017) 0.75

Single-molecule imaging reveals the translocation and DNA looping dynamics of hepatitis C virus NS3 helicase. Protein Sci (2017) 0.75

Articles cited by this

The Ras-RasGAP complex: structural basis for GTPase activation and its loss in oncogenic Ras mutants. Science (1997) 9.21

Replication of hepatitis C virus. Nat Rev Microbiol (2007) 8.31

Structure and mechanism of helicases and nucleic acid translocases. Annu Rev Biochem (2007) 7.83

Crystal structures of complexes of PcrA DNA helicase with a DNA substrate indicate an inchworm mechanism. Cell (1999) 6.84

A new superfamily of replicative proteins. Nature (1988) 6.20

Hepatitis C virus NS3 RNA helicase domain with a bound oligonucleotide: the crystal structure provides insights into the mode of unwinding. Structure (1998) 5.83

Structural basis for RNA unwinding by the DEAD-box protein Drosophila Vasa. Cell (2006) 5.70

Spring-loaded mechanism of DNA unwinding by hepatitis C virus NS3 helicase. Science (2007) 3.70

RNA translocation and unwinding mechanism of HCV NS3 helicase and its coordination by ATP. Nature (2006) 3.67

UvrD helicase unwinds DNA one base pair at a time by a two-part power stroke. Cell (2006) 3.65

Structure of the exon junction core complex with a trapped DEAD-box ATPase bound to RNA. Science (2006) 3.60

Hepatitis C virus NS3 protein polynucleotide-stimulated nucleoside triphosphatase and comparison with the related pestivirus and flavivirus enzymes. J Virol (1993) 3.37

Molecular views of viral polyprotein processing revealed by the crystal structure of the hepatitis C virus bifunctional protease-helicase. Structure (1999) 3.37

Challenges and successes in developing new therapies for hepatitis C. Nature (2005) 3.22

C-terminal domain of the hepatitis C virus NS3 protein contains an RNA helicase activity. Biochem Biophys Res Commun (1995) 3.09

A conserved NTP-motif in putative helicases. Nature (1988) 2.94

NS3 helicase domains involved in infectious intracellular hepatitis C virus particle assembly. J Virol (2008) 2.62

The helicase activity associated with hepatitis C virus nonstructural protein 3 (NS3). J Virol (1996) 2.30

Periodic cycles of RNA unwinding and pausing by hepatitis C virus NS3 helicase. Nature (2004) 2.10

Insights into RNA unwinding and ATP hydrolysis by the flavivirus NS3 protein. EMBO J (2008) 1.99

Mutational analysis of the hepatitis C virus RNA helicase. J Virol (1997) 1.77

The hepatitis C virus NS3 protein: a model RNA helicase and potential drug target. Curr Issues Mol Biol (2007) 1.76

The serine protease domain of hepatitis C viral NS3 activates RNA helicase activity by promoting the binding of RNA substrate. J Biol Chem (2007) 1.70

Mechanistic basis of 5'-3' translocation in SF1B helicases. Cell (2009) 1.65

Structural determinants for membrane association and dynamic organization of the hepatitis C virus NS3-4A complex. Proc Natl Acad Sci U S A (2008) 1.62

The nonstructural protein 3 protease/helicase requires an intact protease domain to unwind duplex RNA efficiently. J Biol Chem (2003) 1.61

Viral and cellular RNA helicases as antiviral targets. Nat Rev Drug Discov (2005) 1.59

Product release is the major contributor to kcat for the hepatitis C virus helicase-catalyzed strand separation of short duplex DNA. J Biol Chem (1998) 1.44

The DEXD/H-box RNA helicase DDX19 is regulated by an {alpha}-helical switch. J Biol Chem (2009) 1.39

Hepatitis C virus NS3 and simian virus 40 T antigen helicases displace streptavidin from 5'-biotinylated oligonucleotides but not from 3'-biotinylated oligonucleotides: evidence for directional bias in translocation on single-stranded DNA. Biochemistry (2002) 1.35

Two novel conserved motifs in the hepatitis C virus NS3 protein critical for helicase action. J Biol Chem (2003) 1.34

RecA-like motor ATPases--lessons from structures. Biochim Biophys Acta (2004) 1.33

ATP binding modulates the nucleic acid affinity of hepatitis C virus helicase. J Biol Chem (2003) 1.33

Structural and biological identification of residues on the surface of NS3 helicase required for optimal replication of the hepatitis C virus. J Biol Chem (2005) 1.28

Structure-based mutational analysis of the hepatitis C virus NS3 helicase. J Virol (2001) 1.26

A point mutation abolishes the helicase but not the nucleoside triphosphatase activity of hepatitis C virus NS3 protein. J Virol (1997) 1.25

Characterization and mutational analysis of the helicase and NTPase activities of hepatitis C virus full-length NS3 protein. J Gen Virol (1999) 1.22

Upregulation of protein phosphatase 2Ac by hepatitis C virus modulates NS3 helicase activity through inhibition of protein arginine methyltransferase 1. J Virol (2005) 1.19

Articles by these authors

(truncated to the top 100)

Complete replication of hepatitis C virus in cell culture. Science (2005) 18.59

Identification of microRNAs of the herpesvirus family. Nat Methods (2005) 12.98

A diverse range of gene products are effectors of the type I interferon antiviral response. Nature (2011) 12.86

Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J Virol (2002) 11.99

Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature (2007) 9.52

Suppression of inflammation by a synthetic histone mimic. Nature (2010) 8.80

Replication of hepatitis C virus. Nat Rev Microbiol (2007) 8.31

Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles. Proc Natl Acad Sci U S A (2003) 8.21

Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature (2009) 8.05

Cellular cofactors affecting hepatitis C virus infection and replication. Proc Natl Acad Sci U S A (2007) 6.79

Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics. Gastroenterology (2006) 6.16

Unravelling hepatitis C virus replication from genome to function. Nature (2005) 5.25

HCV persistence and immune evasion in the absence of memory T cell help. Science (2003) 5.23

Molecular biology of flaviviruses. Adv Virus Res (2003) 4.39

Hepatitis C virus p7 and NS2 proteins are essential for production of infectious virus. J Virol (2007) 4.28

Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource. Hepatology (2014) 4.15

Efficient replication of hepatitis C virus genotype 1a RNAs in cell culture. J Virol (2003) 3.84

Structure of the zinc-binding domain of an essential component of the hepatitis C virus replicase. Nature (2005) 3.83

Time- and temperature-dependent activation of hepatitis C virus for low-pH-triggered entry. J Virol (2006) 3.71

Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro. Proc Natl Acad Sci U S A (2006) 3.69

CD81 is required for hepatitis C virus glycoprotein-mediated viral infection. J Virol (2004) 3.53

Interferon-stimulated genes: a complex web of host defenses. Annu Rev Immunol (2014) 3.47

Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo. Gastroenterology (2006) 3.44

Real-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter system. Nat Biotechnol (2010) 3.44

Interferon-stimulated genes and their antiviral effector functions. Curr Opin Virol (2011) 3.44

Completion of the entire hepatitis C virus life cycle in genetically humanized mice. Nature (2013) 3.39

Insertion of green fluorescent protein into nonstructural protein 5A allows direct visualization of functional hepatitis C virus replication complexes. J Virol (2004) 3.39

Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs. Proc Natl Acad Sci U S A (2002) 3.21

Expression of the zinc-finger antiviral protein inhibits alphavirus replication. J Virol (2003) 3.19

The NS5A protein of hepatitis C virus is a zinc metalloprotein. J Biol Chem (2004) 3.15

A genetically humanized mouse model for hepatitis C virus infection. Nature (2011) 3.15

Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR. J Virol (2003) 3.10

Mutations in the yellow fever virus nonstructural protein NS2A selectively block production of infectious particles. J Virol (2002) 3.07

Cell culture-produced hepatitis C virus does not infect peripheral blood mononuclear cells. Hepatology (2008) 2.91

Phosphorylation of hepatitis C virus nonstructural protein 5A modulates its protein interactions and viral RNA replication. Proc Natl Acad Sci U S A (2004) 2.77

The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response. J Immunol (2009) 2.68

Flying under the radar: the immunobiology of hepatitis C. Annu Rev Immunol (2007) 2.65

Understanding the hepatitis C virus life cycle paves the way for highly effective therapies. Nat Med (2013) 2.63

Structure of the catalytic domain of the hepatitis C virus NS2-3 protease. Nature (2006) 2.58

Humanized mice for modeling human infectious disease: challenges, progress, and outlook. Cell Host Microbe (2009) 2.58

Roles of nonstructural protein nsP2 and Alpha/Beta interferons in determining the outcome of Sindbis virus infection. J Virol (2002) 2.55

Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C. Blood (2005) 2.50

Clonal B cells in patients with hepatitis C virus-associated mixed cryoglobulinemia contain an expanded anergic CD21low B-cell subset. Blood (2011) 2.49

Temporal proteome and lipidome profiles reveal hepatitis C virus-associated reprogramming of hepatocellular metabolism and bioenergetics. PLoS Pathog (2010) 2.48

Identification of residues required for RNA replication in domains II and III of the hepatitis C virus NS5A protein. J Virol (2007) 2.45

Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures. Proc Natl Acad Sci U S A (2010) 2.44

euHCVdb: the European hepatitis C virus database. Nucleic Acids Res (2006) 2.41

MX2 is an interferon-induced inhibitor of HIV-1 infection. Nature (2013) 2.40

Hepatitis C virus kinetics and host responses associated with disease and outcome of infection in chimpanzees. Hepatology (2004) 2.37

A cis-acting replication element in the sequence encoding the NS5B RNA-dependent RNA polymerase is required for hepatitis C virus RNA replication. J Virol (2004) 2.36

Previously infected and recovered chimpanzees exhibit rapid responses that control hepatitis C virus replication upon rechallenge. J Virol (2002) 2.31

Priming of protective T cell responses against virus-induced tumors in mice with human immune system components. J Exp Med (2009) 2.26

A stable full-length yellow fever virus cDNA clone and the role of conserved RNA elements in flavivirus replication. J Gen Virol (2003) 2.25

Modeling hepatitis C virus infection using human induced pluripotent stem cells. Proc Natl Acad Sci U S A (2012) 2.20

Amphipathic helix-dependent localization of NS5A mediates hepatitis C virus RNA replication. J Virol (2003) 2.20

Characterization of a canine homolog of hepatitis C virus. Proc Natl Acad Sci U S A (2011) 2.14

Hepatitis C virus induces interferon-λ and interferon-stimulated genes in primary liver cultures. Hepatology (2011) 2.13

Polymorphisms in melanoma differentiation-associated gene 5 link protein function to clearance of hepatitis C virus. Hepatology (2015) 2.11

Diverse CD81 proteins support hepatitis C virus infection. J Virol (2006) 2.07

A humanized mouse model to study hepatitis C virus infection, immune response, and liver disease. Gastroenterology (2011) 2.06

Mycobacterial disease and impaired IFN-γ immunity in humans with inherited ISG15 deficiency. Science (2012) 2.06

Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus. Proc Natl Acad Sci U S A (2012) 2.05

Oxidized low-density lipoprotein inhibits hepatitis C virus cell entry in human hepatoma cells. Hepatology (2006) 2.04

Induction of interferon-stimulated gene expression and antiviral responses require protein deacetylase activity. Proc Natl Acad Sci U S A (2004) 2.04

Tracking and elucidating alphavirus-host protein interactions. J Biol Chem (2006) 2.01

An N-terminal amphipathic helix in hepatitis C virus (HCV) NS4B mediates membrane association, correct localization of replication complex proteins, and HCV RNA replication. J Virol (2004) 1.99

Kinetics of CD4+ and CD8+ memory T-cell responses during hepatitis C virus rechallenge of previously recovered chimpanzees. J Virol (2003) 1.93

Hepatitis C virus entry. J Biol Chem (2007) 1.91

Interaction between hepatitis C virus proteins and host cell factors. Curr Opin Microbiol (2002) 1.87

CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells. J Gen Virol (2009) 1.87

HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice. Proc Natl Acad Sci U S A (2013) 1.85

PKR-dependent and -independent mechanisms are involved in translational shutoff during Sindbis virus infection. J Virol (2004) 1.81

Serology-enabled discovery of genetically diverse hepaciviruses in a new host. J Virol (2012) 1.80

Uncleaved NS2-3 is required for production of infectious bovine viral diarrhea virus. J Virol (2004) 1.79

Silencing of USP18 potentiates the antiviral activity of interferon against hepatitis C virus infection. Gastroenterology (2006) 1.75

High-avidity monoclonal antibodies against the human scavenger class B type I receptor efficiently block hepatitis C virus infection in the presence of high-density lipoprotein. J Virol (2007) 1.73

Genomic analysis reveals a potential role for cell cycle perturbation in HCV-mediated apoptosis of cultured hepatocytes. PLoS Pathog (2009) 1.73

Alanine scanning of the hepatitis C virus core protein reveals numerous residues essential for production of infectious virus. J Virol (2007) 1.73

Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia. Blood (2007) 1.72

Superinfection exclusion in cells infected with hepatitis C virus. J Virol (2007) 1.71

Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes. J Exp Med (2005) 1.71

Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells. Gut (2014) 1.70

The ins and outs of hepatitis C virus entry and assembly. Nat Rev Microbiol (2013) 1.69

A dynamic view of hepatitis C virus replication complexes. J Virol (2008) 1.66

Virus-induced type I IFN stimulates generation of immunoproteasomes at the site of infection. J Clin Invest (2006) 1.66

Evidence for a functional RNA element in the hepatitis C virus core gene. Proc Natl Acad Sci U S A (2007) 1.64

Studying hepatitis C virus: making the best of a bad virus. J Virol (2007) 1.62

3' RNA elements in hepatitis C virus replication: kissing partners and long poly(U). J Virol (2007) 1.62

Identification of rodent homologs of hepatitis C virus and pegiviruses. MBio (2013) 1.61

Characterization of vesicular stomatitis virus recombinants that express and incorporate high levels of hepatitis C virus glycoproteins. J Virol (2002) 1.61

Architects of assembly: roles of Flaviviridae non-structural proteins in virion morphogenesis. Nat Rev Microbiol (2008) 1.60

Dengue reporter viruses reveal viral dynamics in interferon receptor-deficient mice and sensitivity to interferon effectors in vitro. Proc Natl Acad Sci U S A (2012) 1.48

Mathematical modeling of primary hepatitis C infection: noncytolytic clearance and early blockage of virion production. Gastroenterology (2005) 1.47

Yellow fever 17D as a vaccine vector for microbial CTL epitopes: protection in a rodent malaria model. J Exp Med (2005) 1.46

Expression of paramyxovirus V proteins promotes replication and spread of hepatitis C virus in cultures of primary human fetal liver cells. Hepatology (2011) 1.42

Host factors associated with the Sindbis virus RNA-dependent RNA polymerase: role for G3BP1 and G3BP2 in virus replication. J Virol (2010) 1.38

Hepatitis C virus RNA synthesis in a cell-free system isolated from replicon-containing hepatoma cells. J Virol (2003) 1.36

Histone H3 lysine 9 di-methylation as an epigenetic signature of the interferon response. J Exp Med (2012) 1.36

Dual mechanisms of pestiviral superinfection exclusion at entry and RNA replication. J Virol (2005) 1.35

Development of human CD4+FoxP3+ regulatory T cells in human stem cell factor-, granulocyte-macrophage colony-stimulating factor-, and interleukin-3-expressing NOD-SCID IL2Rγ(null) humanized mice. Blood (2011) 1.35